United States· US:70720-950_c48edbf8-425f-4e11-8892-467e868d9fba

ZOLADEX

A medicinal product containing goserelin acetate, registered in United States by TerSera Therapeutics LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZOLADEXATC—REGISTER NO.US:70720-950_c48edbf8…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GOSERELIN ACETATE
Manufacturer
TerSera Therapeutics LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7072095036
    1 POUCH in 1 CARTON (70720-950-36) / 1 SYRINGE in 1 POUCH / 1 IMPLANT in 1 SYRINGE
  • ndc11
    70720-950-36

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Goserelin acetate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All goserelin acetate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Zoladex Depot
  • Belgium · Zoladex, Zoladex Long Acting
  • Bulgaria · Золадекс, Золадекс Lа
  • Cyprus · Zoladex
  • Czechia · Reseligo, Zoladex Depot
  • Germany · Goserelin Endomedica, Gosgon
  • Denmark · Zoladex
  • Estonia · Reseligo, Zoladex
  • Spain · Zoladex, Zoladex Trimestral
  • Finland · Zoladex
  • France · Zoladex
  • United Kingdom (Northern Ireland) · Zoladex, Zoladex La
  • Greece · Implandex, Implandex La
  • Croatia · Reseligo, Zoladex
  • Hungary · Reseligo, Zildalis
  • Ireland · Zoladex, Zoladex La
  • Iceland · Reseligo, Zoladex
  • Italy · Zoladex
  • Lithuania · Algonad, Reseligo
  • Luxembourg · Zoladex, Zoladex Long Acting
  • Latvia · Reseligo
  • Malta · Golexin, Golexin La
  • Netherlands · Zoladex
  • Norway · Zoladex
  • Poland · Reseligo, Xanderla
  • Portugal · Golexin, Golexin La
  • Romania · Reseligo, Zoladex
  • Sweden · Zoladex
  • Slovenia · Reseligo, Zoladex
  • Slovakia · Reseligo, Zoladex Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8f9b985d-05ff-4345-a6e3-0a3f307e4b75
GET /v1/drugs/8f9b985d-05ff-4345-a6e3-0a3f307e4b75?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "3.6",
  "substance": "GOSERELIN ACETATE",
  "productndc": "70720-950",
  "dosage_form": "IMPLANT",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA019726",
  "marketing_category": "NDA"
}

See everything about goserelin acetate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.